Cancer clinical trials contribute critical information about the safety and efficacy of novel therapies but also provide patients access to cutting-edge treatments. Although trial enrollment has increased over the past 2 decades in the United States, notable differences remain between the sociodemographic profiles of patients affected by cancer and those participating in trials. Specifically, racial and ethnic minority populations, women, and older adults are often under-represented. Read More >>